Table 4.
Parameter | Category | DSS
|
DMFS
|
LRFS
|
||||||
---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | ||
Stage | I–II | 1 | 1 | 1 | ||||||
III–IV | 2.235 | 1.113–4.488 | 0.024* | 2.275 | 1.086–4.767 | 0.029* | 2.210 | 1.222–8.316 | 0.018* | |
Periostin exp. | Low exp. | 1 | 1 | 1 | ||||||
High exp. | 2.311 | 1.327–4.027 | 0.003* | 1.727 | 0.962–3.100 | 0.067 | 3.187 | 1.108–4.408 | 0.024* |
Note:
Statistically significant.
Abbreviations: DSS, disease-specific survival; DMFS, distal metastasis-free Survival.